Santen Pharmaceutical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNPHY research report →
About the company
Santen Pharmaceutical Co. , Ltd. is a global enterprise dedicated to the research, development, manufacturing, and distribution of pharmaceuticals and medical devices, with operations spanning Japan and international markets.
- CEO
- Takeshi Ito
- IPO
- 2011
- Employees
- 3,744
- HQ
- Osaka, JP
Price Chart
- Market Cap
- $4.34B
- P/E
- 19.22
- P/S
- 2.44
- P/B
- 2.42
- EV/EBITDA
- 9.29
- Div Yield
- 1.72%
- Gross Margin
- 55.20%
- Op Margin
- 15.50%
- Net Margin
- 12.81%
- ROE
- 13.15%
- ROIC
- 10.68%
- Revenue
- $309.21B · 3.07%
- Net Income
- $39.62B · 9.29%
- EPS
- $121.43 · 16.78%
- Op Income
- $47.94B
- FCF YoY
- -28.38%
- 52W High
- $13.85
- 52W Low
- $9.22
- 50D MA
- $11.68
- 200D MA
- $10.94
- Beta
- 0.25
- Avg Volume
- 11.11K
Get TickerSpark's AI analysis on SNPHY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SNPHY coverage
Recent articles, reports, and earnings notes.
Want a deeper read on SNPHY?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.